Form 8-K - Current report:
SEC Accession No. 0001193125-25-262508
Filing Date
2025-11-03
Accepted
2025-11-03 16:02:26
Documents
12
Period of Report
2025-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-20251103.htm   iXBRL 8-K 46568
2 EX-99.1 bdsx-ex99_1.htm EX-99.1 344304
3 GRAPHIC img189760734_0.jpg GRAPHIC 10166
  Complete submission text file 0001193125-25-262508.txt   538099

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bdsx-20251103.xsd EX-101.SCH 31878
14 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20251103_htm.xml XML 4698
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 251443972
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)